Business Description
Ascelia Pharma AB
ISIN : SE0010573113
Compare
Compare
Traded in other countries / regions
ACE.Sweden7ZA.GermanyACEs.UK IPO Date
2019-09-27Description
Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo Sweden focused on orphan oncology It develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway The company has two drug candidates Orviglance and Oncoral in clinical development.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.6 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.25 | |||||
| Debt-to-EBITDA | -0.47 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 5 | |||||
| 3-Year EPS without NRI Growth Rate | 5.1 | |||||
| 3-Year FCF Growth Rate | -4.7 | |||||
| 3-Year Book Growth Rate | -35.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 46.27 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.77 | |||||
| Quick Ratio | 3.77 | |||||
| Cash Ratio | 3.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.2 | |||||
| Shareholder Yield % | -6.77 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -82.61 | |||||
| ROA % | -57.48 | |||||
| ROIC % | -78.79 | |||||
| ROC (Joel Greenblatt) % | -6886.25 | |||||
| ROCE % | -62.69 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.59 | |||||
| Price-to-Tangible-Book | 5.47 | |||||
| EV-to-EBIT | -3.67 | |||||
| EV-to-EBITDA | -3.67 | |||||
| EV-to-FCF | -3.49 | |||||
| Price-to-Net-Current-Asset-Value | 5.58 | |||||
| Price-to-Net-Cash | 6.59 | |||||
| Earnings Yield (Greenblatt) % | -27.25 | |||||
| FCF Yield % | -21.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ascelia Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -1.246 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (kr) | 0 | ||
| 20-Day SMA (kr) | 45.05 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (kr) | 45.05 - 45.05 | ||
| Shares Outstanding (Mil) | 96.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ascelia Pharma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ascelia Pharma AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ascelia Pharma AB Frequently Asked Questions
What is Ascelia Pharma AB(CHIX:ACEs)'s stock price today?
The current price of CHIX:ACEs is kr45.05. The 52 week high of CHIX:ACEs is kr45.05 and 52 week low is kr45.05.
When is next earnings date of Ascelia Pharma AB(CHIX:ACEs)?
The next earnings date of Ascelia Pharma AB(CHIX:ACEs) is 2025-02-07.
Does Ascelia Pharma AB(CHIX:ACEs) pay dividends? If so, how much?
Ascelia Pharma AB(CHIX:ACEs) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers